Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Hemmings

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Pharmaceutical Statistics|April 19, 2018
How to use prior knowledge and still give new data a chance?Kristina Weber, Rob Hemmings, Armin Koch
Pharmaceutical Statistics|April 29, 2008
Assessing the impact of ICH E9David Brown, Simon Day, Rob Hemmings, et al.
Clinical Pharmacology and Therapeutics|February 9, 2023
Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial DesignsCornelia Dunger-Baldauf, Rob Hemmings, Frank Bretz, et al.
Pharmaceutical Statistics|September 12, 2007
Conditional approval: discussion points from the PSI conditional approval expert groupKevin Carroll, Hilary Chaudri Ross, Dan Evans, et al.
Nature Reviews. Drug Discovery|February 15, 2023
Application of Bayesian approaches in drug development: starting a virtuous cycleStephen J Ruberg, Francois Beckers, Rob Hemmings, et al.
Pharmaceutical Statistics|December 27, 2024
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial SponsorsKonstantinos Sechidis, Sophie Sun, Yao Chen, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Pharmaceutical Statistics|April 19, 2018
How to use prior knowledge and still give new data a chance?Kristina Weber, Rob Hemmings, Armin Koch
Pharmaceutical Statistics|April 29, 2008
Assessing the impact of ICH E9David Brown, Simon Day, Rob Hemmings, et al.
Clinical Pharmacology and Therapeutics|February 9, 2023
Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial DesignsCornelia Dunger-Baldauf, Rob Hemmings, Frank Bretz, et al.
Pharmaceutical Statistics|September 12, 2007
Conditional approval: discussion points from the PSI conditional approval expert groupKevin Carroll, Hilary Chaudri Ross, Dan Evans, et al.
Nature Reviews. Drug Discovery|February 15, 2023
Application of Bayesian approaches in drug development: starting a virtuous cycleStephen J Ruberg, Francois Beckers, Rob Hemmings, et al.
Pharmaceutical Statistics|December 27, 2024
WATCH: A Workflow to Assess Treatment Effect Heterogeneity in Drug Development for Clinical Trial SponsorsKonstantinos Sechidis, Sophie Sun, Yao Chen, et al.
Pageof 1